Clinical Trials Logo

Clinical Trial Summary

To develop and evaluate a pharmaceutical formula based on green banana peel extract for the treatment of melasma.


Clinical Trial Description

Objective: to develop and evaluate a pharmaceutical formula based on green banana peel extract for the treatment of melasma. Methods: it will be a clinical, interventional, longitudinal study, random sampling, Sample will have 60 patients divided into two groups. In the Control Group, SPF 30 sunscreen plus pharmaceutical formulation without green banana peel extract will be used, and in the Study Group, in addition to SPF 30 sunscreen, pharmaceutical formulation containing green banana peel extract will be used. Patients will undergo treatment for 90 days, evaluated every 30 days through clinical evaluation and MELASQol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05031689
Study type Interventional
Source Universidade do Vale do Sapucai
Contact
Status Completed
Phase Phase 1
Start date June 30, 2021
Completion date August 10, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05013801 - A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma N/A
Completed NCT01695356 - Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma Phase 4
Recruiting NCT04597203 - Efficacy and Safety of Using Combination of 755-nm Picosecond Alexandrite Laser and 2% Hydroquinone Compared With 2% Hydroquinone Alone for the Treatment of Melasma: a Randomized Split-face Controlled Trial N/A
Completed NCT02138539 - Evaluation of an Herbal-Based De-Pigmenting System Phase 4
Recruiting NCT01661556 - Clinical Trial of Hydroquinone Versus Miconazol in Melasma Phase 4
Completed NCT01001624 - Melanil in the Treatment of Melasma Phase 3
Active, not recruiting NCT03415685 - Lutronic PicoPlus Exploratory Clinical Trial N/A
Recruiting NCT04765930 - Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in Melasma N/A
Completed NCT04137263 - Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging N/A
Recruiting NCT03686787 - Oral Tranexamic Acid and Laser for Treatment of Melasma Phase 4
Completed NCT00500162 - Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma Phase 4
Completed NCT00472966 - Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma Phase 4
Recruiting NCT03308370 - Platelet Rich Plasma in Treatment of Melasma Phase 3
Completed NCT01162850 - Oral Polypodium Leucotomos for Melasma N/A
Completed NCT00467233 - Study of Acid Peel and Laser for the Treatment of Melasma N/A
Completed NCT00469183 - Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma Phase 4
Completed NCT02730819 - Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma Phase 2
Completed NCT03963466 - A Clinical Observation of 1064-nm Q-Switched Fractional Laser Combined With Oral Tranexamic Acid on Treating of Melasma. N/A
Completed NCT03674203 - Efficacy of Platelet-rich Plasma in Treatment of Melasma Phase 2
Completed NCT03040089 - Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm N/A